CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) saw a significant increase in short interest during the month of October. As of October 15th, there was short interest totalling 7,100 shares, an increase of 14.5% from the September 30th total of 6,200 shares. Based on an average daily trading volume, of 59,900 shares, the days-to-cover ratio is currently 0.1 days.
CSPC Pharmaceutical Group Price Performance
OTCMKTS CSPCY traded up C$0.01 on Tuesday, reaching C$3.15. The stock had a trading volume of 4,898 shares, compared to its average volume of 42,179. CSPC Pharmaceutical Group has a 12-month low of C$2.25 and a 12-month high of C$3.82. The business’s 50-day moving average price is C$2.81 and its 200 day moving average price is C$3.05.
CSPC Pharmaceutical Group Increases Dividend
The business also recently declared a dividend, which will be paid on Thursday, December 5th. Stockholders of record on Friday, November 1st will be paid a dividend of $0.0575 per share. The ex-dividend date is Friday, November 1st. This is a boost from CSPC Pharmaceutical Group’s previous dividend of $0.06.
About CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.
Featured Articles
- Five stocks we like better than CSPC Pharmaceutical Group
- What is the NASDAQ Stock Exchange?
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- How to Invest in the Best Canadian StocksĀ
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- What is a Low P/E Ratio and What Does it Tell Investors?
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.